Literature DB >> 24961756

Molecular subtype classification of formalin-fixed, paraffin-embedded diffuse large B-cell lymphoma samples on the ICEPlex® system.

Angela M B Collie1, Jörk Nölling, Kiran M Divakar, Jeffrey J Lin, Paula Carver, Lisa M Durkin, Brian T Hill, Mitchell R Smith, Tomas Radivoyevitch, Lilly I Kong, Thomas Daly, Gurunathan Murugesan, Jeanna Guenther-Johnson, Sandeep S Dave, Elena A Manilich, Eric D Hsi.   

Abstract

Entities:  

Keywords:  biological assay; diffuse large B-cell lymphoma; gene expression profiling; multiplex polymerase chain reaction; non-hodgkin lymphoma

Mesh：

Substances：

Year:  2014        PMID： 24961756      PMCID： PMC4188713          DOI： 10.1111/bjh.12983

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.

Authors:  George Wright; Bruce Tan; Andreas Rosenwald; Elaine H Hurt; Adrian Wiestner; Louis M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-04       Impact factor: 11.205

2.  Automated high multiplex qPCR platform for simultaneous detection and quantification of multiple nucleic acid targets.

Authors:  Louis Hlousek; Sergey Voronov; Vesselin Diankov; Amy B Leblang; Patrick J Wells; Donna M Ford; Jork Nolling; Kyle W Hart; Patricio A Espinoza; Michael R Bristol; Gregory J Tsongalis; Belinda Yen-Lieberman; Vladimir I Slepnev; Lilly I Kong; Ming-Chou Lee
Journal:  Biotechniques       Date:  2012-05       Impact factor: 1.993

3.  Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue.

Authors:  David W Scott; George W Wright; P Mickey Williams; Chih-Jian Lih; William Walsh; Elaine S Jaffe; Andreas Rosenwald; Elias Campo; Wing C Chan; Joseph M Connors; Erlend B Smeland; Anja Mottok; Rita M Braziel; German Ott; Jan Delabie; Raymond R Tubbs; James R Cook; Dennis D Weisenburger; Timothy C Greiner; Betty J Glinsmann-Gibson; Kai Fu; Louis M Staudt; Randy D Gascoyne; Lisa M Rimsza
Journal:  Blood       Date:  2014-01-07       Impact factor: 22.113

4.  Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium.

Authors:  Gilles Salles; Daphne de Jong; Wanling Xie; Andreas Rosenwald; Mukesh Chhanabhai; Philippe Gaulard; Wolfram Klapper; Maria Calaminici; Birgitta Sander; Christoph Thorns; Elias Campo; Thierry Molina; Abigail Lee; Michael Pfreundschuh; Sandra Horning; Andrew Lister; Laurie H Sehn; John Raemaekers; Anton Hagenbeek; Randy D Gascoyne; Edie Weller
Journal:  Blood       Date:  2011-05-02       Impact factor: 22.113

5.  Genetic heterogeneity of diffuse large B-cell lymphoma.

Authors:  Jenny Zhang; Vladimir Grubor; Cassandra L Love; Anjishnu Banerjee; Kristy L Richards; Piotr A Mieczkowski; Cherie Dunphy; William Choi; Wing Yan Au; Gopesh Srivastava; Patricia L Lugar; David A Rizzieri; Anand S Lagoo; Leon Bernal-Mizrachi; Karen P Mann; Christopher Flowers; Kikkeri Naresh; Andrew Evens; Leo I Gordon; Magdalena Czader; Javed I Gill; Eric D Hsi; Qingquan Liu; Alice Fan; Katherine Walsh; Dereje Jima; Lisa L Smith; Amy J Johnson; John C Byrd; Micah A Luftig; Ting Ni; Jun Zhu; Amy Chadburn; Shawn Levy; David Dunson; Sandeep S Dave
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-04       Impact factor: 11.205

6.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.

Authors:  A A Alizadeh; M B Eisen; R E Davis; C Ma; I S Lossos; A Rosenwald; J C Boldrick; H Sabet; T Tran; X Yu; J I Powell; L Yang; G E Marti; T Moore; J Hudson; L Lu; D B Lewis; R Tibshirani; G Sherlock; W C Chan; T C Greiner; D D Weisenburger; J O Armitage; R Warnke; R Levy; W Wilson; M R Grever; J C Byrd; D Botstein; P O Brown; L M Staudt
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

7.  Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker Consortium.

Authors:  Daphne de Jong; Andreas Rosenwald; Mukesh Chhanabhai; Philippe Gaulard; Wolfram Klapper; Abigail Lee; Birgitta Sander; Christoph Thorns; Elias Campo; Thierry Molina; Andrew Norton; Anton Hagenbeek; Sandra Horning; Andrew Lister; John Raemaekers; Randy D Gascoyne; Gilles Salles; Edie Weller
Journal:  J Clin Oncol       Date:  2007-03-01       Impact factor: 44.544

8.  Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium).

Authors:  D de Jong; W Xie; A Rosenwald; M Chhanabhai; P Gaulard; W Klapper; A Lee; B Sander; C Thorns; E Campo; T Molina; A Hagenbeek; S Horning; A Lister; J Raemaekers; G Salles; R D Gascoyne; E Weller
Journal:  J Clin Pathol       Date:  2008-09-15       Impact factor: 3.411

9.  Stromal gene signatures in large-B-cell lymphomas.

Authors:  G Lenz; G Wright; S S Dave; W Xiao; J Powell; H Zhao; W Xu; B Tan; N Goldschmidt; J Iqbal; J Vose; M Bast; K Fu; D D Weisenburger; T C Greiner; J O Armitage; A Kyle; L May; R D Gascoyne; J M Connors; G Troen; H Holte; S Kvaloy; D Dierickx; G Verhoef; J Delabie; E B Smeland; P Jares; A Martinez; A Lopez-Guillermo; E Montserrat; E Campo; R M Braziel; T P Miller; L M Rimsza; J R Cook; B Pohlman; J Sweetenham; R R Tubbs; R I Fisher; E Hartmann; A Rosenwald; G Ott; H-K Muller-Hermelink; D Wrench; T A Lister; E S Jaffe; W H Wilson; W C Chan; L M Staudt
Journal:  N Engl J Med       Date:  2008-11-27       Impact factor: 91.245

10.  Poor concordance among nine immunohistochemistry classifiers of cell-of-origin for diffuse large B-cell lymphoma: implications for therapeutic strategies.

Authors:  Rita Coutinho; Andrew James Clear; Andrew Owen; Andrew Wilson; Janet Matthews; Abigail Lee; Rute Alvarez; Maria Gomes da Silva; José Cabeçadas; Maria Calaminici; John G Gribben
Journal:  Clin Cancer Res       Date:  2013-10-11       Impact factor: 12.531
  10 in total
  3 in total

Review 1.  Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine.

Authors:  Ruifang Sun; L Jeffrey Medeiros; Ken H Young
Journal:  Mod Pathol       Date:  2016-08-01       Impact factor: 7.842

Review 2.  Evolution of frontline treatment of diffuse large B-cell lymphoma: a brief review and recent update.

Authors:  Jung Yong Hong; Cheolwon Suh; Won Seog Kim
Journal:  F1000Res       Date:  2016-08-08

3.  Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC.

Authors:  Chen-Chen Zhao; Yang Jiao; Yi-Yin Zhang; Jie Ning; Yi-Ruo Zhang; Jing Xu; Wei Wei; Gu Kang-Sheng
Journal:  Cell Death Dis       Date:  2019-03-15       Impact factor: 8.469
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.